You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Most commonly associated with test analysis, such tools are also seeing uptake by large reference labs for applications like specimen routing and billing support.
With $10 billion in federal funding supporting school screening, labs, vendors, and various other institutions are ramping up efforts to roll out K-12 testing programs.
The firm is using Mesa Biotech's Accula system for the testing, beginning Thursday, the start of the 2021 MLB season.
News items for the in vitro diagnostics industry for the week of Feb. 22, 2021.
The company has performed 100,000 rapid tests for SARS-CoV-2 to date for a variety of organizations, including sports leagues and public schools.
The company's service revenues increased 157 percent to $457.9 million due to significant COVID-19 testing volumes, slightly offset by lower base business volumes.
News items for the in vitro diagnostics industry for the week of Jan. 25, 2021.
While the approach has been promoted as a tool for expanding testing capacity, high rates of infection and implementation challenges have led to low uptake.
Demand for SARS-CoV-2 testing sent lab revenues soaring while changes in patterns of patient care and regulations that could have impacts for years to come.
While SARS-CoV-2 test demand will likely remain strong well into 2021, the question of what to do with the built-up capacity in a post-COVID-19 environment looms.